ストックスクリーナーアプリを入手
12.06
0.50%
0.06
前日終値:
$12.00
開ける：
$11.98
24時間の取引高:
199.04K
Relative Volume:
0.36
時価総額：
$658.03M
収益：
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
+1.26%
1か月 パフォーマンス:
+8.45%
6か月 パフォーマンス:
-11.78%
1年 パフォーマンス:
+0.00%
1日の値動き範囲:
$11.56
$12.12
1週間の範囲:
$11.47
$12.19
52週間の値動き範囲:
$7.80
$28.09
Bicara Therapeutics Inc Stock (BCAX) Company Profile
名前
Bicara Therapeutics Inc
セクター
電話
617-468-4219
住所
116 HUNTINGTON AVENUE SUITE 703, BOSTON
BCAX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
BCAX
Bicara Therapeutics Inc
|
12.06 | 649.30M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Bicara Therapeutics Inc Stock (BCAX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-08-19 | 開始されました | Piper Sandler | Overweight |
| 2025-05-23 | アップグレード | Wells Fargo | Underweight → Equal Weight |
| 2025-04-17 | 開始されました | Wells Fargo | Underweight |
| 2025-02-06 | 開始されました | Wedbush | Outperform |
| 2024-12-06 | 開始されました | H.C. Wainwright | Buy |
| 2024-11-05 | 開始されました | Rodman & Renshaw | Buy |
| 2024-10-08 | 開始されました | Cantor Fitzgerald | Overweight |
| 2024-10-08 | 開始されました | Morgan Stanley | Overweight |
| 2024-10-08 | 開始されました | Stifel | Buy |
| 2024-10-08 | 開始されました | TD Cowen | Buy |
すべてを表示
Bicara Therapeutics Inc (BCAX) 最新ニュース
A | Will Bicara Therapeutics Inc. outperform tech stocksEarnings Summary Report & Safe Entry Zone Tips - khodrobank.com
Applying Elliott Wave Theory to Bicara Therapeutics Inc.July 2025 Update & Safe Capital Allocation Plans - Newser
Regression analysis insights on Bicara Therapeutics Inc. performanceWeekly Trade Report & Technical Confirmation Trade Alerts - Newser
Can Bicara Therapeutics Inc. sustain earnings growthWeekly Stock Analysis & Expert Curated Trade Setup Alerts - khodrobank.com
Bicara Therapeutics: A Promising Yet Niche Player in the HNSCC Market - AInvest
Bicara Therapeutics: Promising, But Only For The Patient (NASDAQ:BCAX) - Seeking Alpha
Technical signs of recovery in Bicara Therapeutics Inc.Quarterly Portfolio Report & Low Risk Investment Opportunities - Newser
Will breakout in Bicara Therapeutics Inc. lead to full recoveryMarket Movement Recap & Safe Entry Zone Identification - Newser
Will Bicara Therapeutics Inc. see short term momentumWeekly Profit Analysis & Free High Accuracy Swing Entry Alerts - Newser
What to expect from Bicara Therapeutics Inc. in the next 30 daysWeekly Loss Report & Weekly High Return Forecasts - Newser
Bicara Therapeutics Inc. stock momentum explained2025 Volatility Report & Fast Entry High Yield Tips - Newser
Is Bicara Therapeutics Inc. being accumulated by smart moneyJuly 2025 Review & Risk Managed Trade Strategies - khodrobank.com
Ranking Bicara Therapeutics Inc. among high performing stocks via toolsBuy Signal & Risk Controlled Stock Alerts - Newser
Bicara Therapeutics Inc. stock trend outlook and recovery path2025 Risk Factors & Expert Approved Trade Ideas - Newser
How moving averages guide Bicara Therapeutics Inc. tradingPortfolio Risk Summary & Real-Time Market Trend Scan - Newser
What’s the profit margin of Bicara Therapeutics Inc.July 2025 Institutional & Long-Term Safe Return Strategies - khodrobank.com
Can Bicara Therapeutics Inc. rally from current levelsPortfolio Risk Summary & Risk Adjusted Swing Trade Ideas - Newser
Sentiment analysis tools applied to Bicara Therapeutics Inc.Take Profit & Consistent Growth Equity Picks - Newser
How to escape a deep drawdown in Bicara Therapeutics Inc.Portfolio Gains Summary & Daily Chart Pattern Signals - Newser
Published on: 2025-09-03 09:02:39 - Newser
Should I invest in Bicara Therapeutics Inc. before earningsJuly 2025 Weekly Recap & High Return Trade Guides - khodrobank.com
How to track smart money flows in Bicara Therapeutics Inc.Treasury Yields & AI Powered Market Entry Strategies - Newser
Published on: 2025-09-02 14:57:05 - Newser
Advanced analytics toolkit walkthrough for Bicara Therapeutics Inc.2025 Breakouts & Breakdowns & Real-Time Market Sentiment Alerts - Newser
Bicara Therapeutics Inc. stock volume spike explainedWeekly Trade Summary & Weekly High Return Forecasts - Newser
Does Bicara Therapeutics Inc. align with a passive investing strategyMarket Trend Report & Intraday High Probability Alerts - khodrobank.com
Is now a turning point for Bicara Therapeutics Inc.2025 Support & Resistance & Fast Gaining Stock Reports - Newser
What recovery options are there for Bicara Therapeutics Inc.July 2025 Decliners & Fast Gaining Stock Strategy Reports - Newser
How to use Fibonacci retracement on Bicara Therapeutics Inc.Quarterly Profit Report & Weekly High Conviction Ideas - Newser
Income Plays: What’s the profit margin of Bicara Therapeutics Inc.July 2025 News Drivers & Comprehensive Market Scan Reports - khodrobank.com
Can Bicara Therapeutics Inc. outperform under higher oil pricesRate Cut & Weekly Watchlist of Top Performers - khodrobank.com
What’s next for Bicara Therapeutics Inc. stockTrade Analysis Summary & High Win Rate Trade Alerts - khodrobank.com
Institutional scanner results for Bicara Therapeutics Inc.Buy Signal & Weekly Stock Performance Updates - Newser
Is Bicara Therapeutics Inc. stock overvalued or fairly pricedExit Point & Short-Term Swing Trade Alerts - khodrobank.com
Is it time to cut losses on Bicara Therapeutics Inc.Watch List & Fast Entry Momentum Alerts - Newser
Visualizing Bicara Therapeutics Inc. stock with heatmapsWeekly Risk Summary & AI Powered Market Trend Analysis - Newser
Is Bicara Therapeutics Inc. stock poised for growthWeekly Gains Report & Low Risk Entry Point Tips - Newser
What’s the recovery path for long term holders of Bicara Therapeutics Inc.Weekly Investment Recap & Reliable Breakout Forecasts - Newser
Bicara Therapeutics Inc (BCAX) 財務データ
Bicara Therapeutics Inc (BCAX) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
Bicara Therapeutics Inc (BCAX) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Meisner Lara | Chief Legal Officer |
Jun 16 '25 |
Sale |
10.43 |
15,829 |
165,096 |
0 |
1.75%
1.11%
大文字化:
|
ボリューム (24 時間):